Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumorsSamuel Cheshier, Michael S. B. Edwards, Gary K. Steinberg et al.|Science Translational Medicine|2017Cited by 427